List of Inotek Pharmaceuticals patents

List of Inotek Pharmaceuticals patents

List of Varian Medical Systems patents

List of Obalon Therapeutics patents

List of Blue Belt Technologies patents

List of funding rounds for Signaturit

List of Tracker Capital Management portfolio companies

Patents where

Current Assignee

Name

is

Inotek Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9370530 Combination, kit and method of reducing intraocular pressure	Patent 9370530 was granted and assigned to Inotek Pharmaceuticals on June, 2016 by the United States Patent and Trademark Office.	Inotek Pharmaceuticals	Inotek Pharmaceuticals		United States Patent and Trademark Office	9370530	June 21, 2016
	‌ US Patent 8476247 Method of reducing intraocular pressure in humans	Patent 8476247 was granted and assigned to Inotek Pharmaceuticals on July, 2013 by the United States Patent and Trademark Office.		Inotek Pharmaceuticals		United States Patent and Trademark Office	8476247	July 2, 2013
	‌ US Patent 8119654 Indenoisoquinolinone analogs and methods of use thereof	Patent 8119654 was granted and assigned to Inotek Pharmaceuticals on February, 2012 by the United States Patent and Trademark Office.		Inotek Pharmaceuticals		United States Patent and Trademark Office	8119654	February 21, 2012
	‌ US Patent 7863253 Purine Derivatives and methods of use thereof	Patent 7863253 was granted and assigned to Inotek Pharmaceuticals on January, 2011 by the United States Patent and Trademark Office.		Inotek Pharmaceuticals		United States Patent and Trademark Office	7863253	January 4, 2011
	‌ US Patent 8455457 Combination compositions for reducing intraocular pressure	Patent 8455457 was granted and assigned to Inotek Pharmaceuticals on June, 2013 by the United States Patent and Trademark Office.		Inotek Pharmaceuticals		United States Patent and Trademark Office	8455457	June 4, 2013
	‌ US Patent 8183224 Purine derivatives as adenosine A	Patent 8183224 was granted and assigned to Inotek Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office.		Inotek Pharmaceuticals		United States Patent and Trademark Office	8183224	May 22, 2012
	‌ US Patent 9278991 Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof	Patent 9278991 was granted and assigned to Inotek Pharmaceuticals on March, 2016 by the United States Patent and Trademark Office.	Inotek Pharmaceuticals	Inotek Pharmaceuticals		United States Patent and Trademark Office	9278991	March 8, 2016
	‌ US Patent 9718853 Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-YL)-3,4-dihydroxytetrahydrofuran-2-YL)] methyl nitrate and processes of preparation thereof	Patent 9718853 was granted and assigned to Inotek Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.	Inotek Pharmaceuticals	Inotek Pharmaceuticals		United States Patent and Trademark Office	9718853	August 1, 2017
	‌ US Patent 9289383 Method of reducing intraocular pressure in humans	Patent 9289383 was granted and assigned to Inotek Pharmaceuticals on March, 2016 by the United States Patent and Trademark Office.	Inotek Pharmaceuticals	Inotek Pharmaceuticals		United States Patent and Trademark Office	9289383	March 22, 2016
	‌ US Patent 8470800 Method of reducing intraocular pressure in humans	Patent 8470800 was granted and assigned to Inotek Pharmaceuticals on June, 2013 by the United States Patent and Trademark Office.		Inotek Pharmaceuticals		United States Patent and Trademark Office	8470800	June 25, 2013
	‌ US Patent 8173130 Antibodies against flagellin and uses thereof	Patent 8173130 was granted and assigned to Inotek Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office.		Inotek Pharmaceuticals		United States Patent and Trademark Office	8173130	May 8, 2012
	‌ US Patent 9522160 Ophthalmic formulations	Patent 9522160 was granted and assigned to Inotek Pharmaceuticals on December, 2016 by the United States Patent and Trademark Office.	Inotek Pharmaceuticals	Inotek Pharmaceuticals		United States Patent and Trademark Office	9522160	December 20, 2016
	‌ US Patent 8895530 Method of reducing intraocular pressure in humans	Patent 8895530 was granted and assigned to Inotek Pharmaceuticals on November, 2014 by the United States Patent and Trademark Office.	Inotek Pharmaceuticals	Inotek Pharmaceuticals		United States Patent and Trademark Office	8895530	November 25, 2014
	‌ US Patent 8877732 Combination, kit and method of reducing intraocular pressure	Patent 8877732 was granted and assigned to Inotek Pharmaceuticals on November, 2014 by the United States Patent and Trademark Office.		Inotek Pharmaceuticals		United States Patent and Trademark Office	8877732	November 4, 2014
	‌ US Patent 8133880 Purine derivatives and methods of use thereof	Patent 8133880 was granted and assigned to Inotek Pharmaceuticals on March, 2012 by the United States Patent and Trademark Office.		Inotek Pharmaceuticals		United States Patent and Trademark Office	8133880	March 13, 2012
	‌ US Patent 8440639 Combination compositions for reducing intraocular pressure	Patent 8440639 was granted and assigned to Inotek Pharmaceuticals on May, 2013 by the United States Patent and Trademark Office.		Inotek Pharmaceuticals		United States Patent and Trademark Office	8440639	May 14, 2013
	‌ US Patent 8609833 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof			Inotek Pharmaceuticals		United States Patent and Trademark Office	8609833	December 17, 2013
	‌ US Patent 8501708 Adenosine compounds and their use thereof	Patent 8501708 was granted and assigned to Inotek Pharmaceuticals on August, 2013 by the United States Patent and Trademark Office.		Inotek Pharmaceuticals		United States Patent and Trademark Office	8501708	August 6, 2013

18 results

0 selected

18 results

0 selected